Induction of myocardial PDCD4 in coronary microembolization-related cardiac dysfunction: Evidence from a large-animal study

Cellular Physiology and Biochemistry

Volumn 34, Issue 2, 2014, Pages 533-542

  Su, Qiang ^a   Li, Lang ^a   Zhou, You ^a   Wang, Jiangyou ^a   Liu, Yangchun ^a   Ma, Guotian ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Cardiac function; Coronary microembolization; PDCD4; Percutaneous intervention

Indexed keywords

CASPASE 3; MEMBRANE PROTEIN; MICROSPHERE; POLYETHYLENE; PROGRAMMED CELL DEATH 4; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; PRIMER DNA; MESSENGER RNA; PDCD4 PROTEIN; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAMA MINIATURE PIG; CONTROL GROUP; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY MICROEMBOLIZATION; FEMALE; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE; MALE; MINIPIG; MYOCARDITIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; EMBOLISM; HEART; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SWINE; CORRELATION ANALYSIS; HEART DISEASE; HISTOPATHOLOGY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; PROTEIN ANALYSIS; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; STAINING;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; BASE SEQUENCE; BLOTTING, WESTERN; DNA PRIMERS; EMBOLISM; FEMALE; HEART; MALE; MICROSPHERES; MYOCARDIUM; REAL-TIME POLYMERASE CHAIN REACTION; SWINE; SWINE, MINIATURE;

ANIMALIA;

EID: 84907375760     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000363020     Document Type: Article

References (21)

1. Heusch G, Kleinbongard P, Böse D, Levkau B, Haude M, Schulz R, Erbel R: Coronary microembolization: from bedside to bench and back to bedside. Circulation 2009;120:1822-1836.
2. Böse D, von Birgelen C, Zhou XY, Schmermund A, Philipp S, Sack S, Konorza T, Möhlenkamp S, Leineweber K, Kleinbongard P, Wijns W, Heusch G, Erbel R: Impact of atherosclerotic plaque composition on coronary microembolization during percutaneous coronary interventions. Basic Res Cardiol 2008;103:587-597.
3. Ma JY, Qian JY, Jin H, et al: Acute hyperenhancement on delayed contrast-enhanced magnetic resonance imaging is the characteristic sign after coronary microembolization. Chin. Med J [Engl] 2009;122:687-691.
4. Otto S, Seeber M, Fujita B, Kretzschmar D, Ferrari M, Goebel B, Figulla HR, Poerner TC: Microembolization and myonecrosis during elective percutaneous coronary interventions in diabetic patients: an intracoronary Doppler ultrasound study with 2-year clinical follow-up. Basic Res Cardiol 2012;107:289.
5. Bahrmann P, Werner GS, Heusch G, Ferrari M, Poerner TC, Voss A, Figulla HR: Detection of coronary microembolization by Doppler ultrasound in patients with stable angina pectoris undergoing elective percutaneous coronary interventions. Circulation 2007;115:600-608.
6. Li L, Zhao X, Lu Y, Huang W, Wen W: Altered expression of pro- and anti-inflammatory cytokines is associated with reduced cardiac function in rats following coronary microembolization. Mol Cell Biochem 2010;342:183-190.
7. Dörge H, Schulz R, Belosjorow S, Post H, van de Sand A, Konietzka I, Frede S, Hartung T, Vinten-Johansen J, Youker KA, Entman ML, Erbel R, Heusch G. Coronary microembolization: the role of TNF-alpha in contractile dysfunction. J Mol Cell Cardiol. 2002;34:51-62.
8. Dörge H, Neumann T, Behrends M, Skyschally A, Schulz R, Kasper C, Erbel R, Heusch G: Perfusion-contraction mismatch with coronary microvascular obstruction: role of inflammation. Am J Physiol Heart Circ Physiol 2000;279:H2587-H2592.
9. Canton M, Skyschally A, Menabò R, Boengler K, Gres P, Schulz R, Haude M, Erbel R, Di Lisa F, Heusch G: Oxidative modification of tropomyosin and myocardial dysfunction following coronary microembolization. Eur Heart J 2006;27:875-881.
10. Thielmann M, Dörge H, Martin C, Belosjorow S, Schwanke U, van De Sand A, Konietzka I, Büchert A, Krüger A, Schulz R, Heusch G: Myocardial dysfunction with coronary microembolization: signal transduction through a sequence of nitric oxide, tumor necrosis factor-alpha, and sphingosine. Circ Res 2002;90:807-813.
11. Wang Q, Dong Z, Liu X, Song X, Song Q, Shang Q, Jiang Y, Guo C, Zhang L: Programmed cell death-4 deficiency prevents diet-induced obesity, adipose tissue inflammation, and insulin resistance. Diabetes 2013;62:4132-4143.
12. Cheng Y, Zhu P, Yang J, Liu X, Dong S, Wang X, Chun B, Zhuang J, Zhang C: Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. Cardiovasc Res 2010;87:431-439.
13. Su Q, Li L, Liu Y, Zhou Y, Wang J, Sun Y. Effect of intensive atorvastatin therapy on periprocedural PDCD4 expression in CD4+ T lymphocytes of patients with unstable angina undergoing percutaneous coronary intervention. Cardiology 2014;127:169-75.
14. Herrmann J, Lerman A, Baumgart D, Volbracht L, Schulz R, von Birgelen C, Haude M, Heusch G, Erbel R: Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction. Circulation 2002;106:2180-2183.
15. Chen C, Hu Q, Yan J, Yang X, Shi X, Lei J, Chen L, Huang H, Han J, Zhang JH, Zhou C: Early inhibition of HIF-1alpha with small interfering RNA reduces ischemic-reperfused brain injury in rats. Neurobiol Dis 2009;33:509-517.
16. Skyschally A, Gres P, Hoffmann S, Haude M, Erbel R, Schulz R, Heusch G: Bidirectional role of tumor necrosis factor-alpha in coronary microembolization: progressive contractile dysfunction versus delayed protection against infarction. Circ Res 2007;100:140-146.
17. Li L, Qu N, Li DH, et al: Coronary microembolization induced myocardial contractile dysfunction and tumor necrosis factor-alpha mRNA expression partly inhibited by SB203580 through a p38 mitogen-activated protein kinase pathway. Chin. Med J [Engl] 2011;124:100-105.
18. Lu Y, Li L, Zhao X, Huang W, Wen W: Beta blocker metoprolol protects against contractile dysfunction in rats after coronary microembolization by regulating expression of myocardial inflammatory cytokines. Life Sci 2011;88:1009-1015.
19. Zhang Z, Zha Y, Hu W, Huang Z, Gao Z, Zang Y, Chen J, Dong L, Zhang J: The autoregulatory feedback loop of MicroRNA-21/Programmed cell death Protein 4/activation Protein-1 (MiR-21/PDCD4/AP-1) as a driving Force for hepatic fibrosis development. J Biol Chem 2013;288:37082-37093.
20. Hilliard A, Hilliard B, Zheng SJ, Sun H, Miwa T, Song W, Göke R, Chen YH: Translational regulation of autoimmune inflammation and lymphoma genesis by programmed cell death 4. J Immunol 2006;177:8095-8102.
21. Dong S, Cheng Y, Yang J, Li J, Liu X, Wang X, Wang D, Krall TJ, Delphin ES, Zhang C: MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J Biol Chem 2009;284:29514-29525.